Imbolc Partners
Syndicate
SEC-registered adviser
Investment syndicate. 1 deal vehicle (SPVs) filed with the SEC since Feb 2025.
“PRE-SEED CAPITAL FOR EMERGING COMPANIES Imbolc Partners I Novel therapeutics for Crohn's Disease and related auto-immune disorders The definitive data platformfor environmental, health & safety tracking Quantum electrochemistry to advancedrug discovery Personalized healthcare execution engine to simplify benefits and boost satisfaction. Satellite-powered parametric climate insurancefor farmers, ra” (from the firm’s website)
- Stages
- Pre-seed, Seed
- Typical check (est.)
- $25K–$50K
- Latest fund
- None on file
- Last verified activity
- Feb 2025
Focus
HealthcareBiotech & PharmaAI & MLClimate & EnergyRecent portfolio activity
- Feb 2025
Imbolc I
SPV
Funds and vehicles on SEC file
- Feb 2025
Imbolc I a Series of Imbolc Partners LLC
Deal vehicle · $3.5M offering
Sources
- SEC Form D: Imbolc I a Series of Imbolc Partners LLCFeb 12, 2025
- SEC adviser record: Imbolc PartnersFeb 6, 2026
- Firm websiteOct 12, 2026
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.